Herein, we summarized the progress of the mechanisms of HER3 in drug resistance, current therapeutic approaches, and some potential molecules targeting HER3, aiming to provide new insights into drug design and cancer therapy for HER3. The gene discussed is ERBB3; the disease is cancer.